KINIKSA PHARMACEUTICALS (UK), LTD. - Profile & Financials

CompanyTrack

Accounts Submitted 27 Sept 2025 Next due 30 Sept 2026 2 months remaining

Confirmation Submitted 14 Nov 2025 Next due 28 Nov 2026 4 months remaining

Net assets £695M £13M 2024 year on year

Total assets £800M £26M 2024 year on year

Total Liabilities £105M £39M 2024 year on year

Charges None No charges registered

Contact & Details

Contact

Registered Address

105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for KINIKSA PHARMACEUTICALS (UK), LTD. (11716038), an active life sciences and medical technology company based in London, England. Incorporated 6 Dec 2018. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2024

Type audit-exemption-subsidiary

Next accounts 31 Dec 2025

Due by 30 Sept 2026 2 months remaining

Balance Sheet & P&L (2019–2024)

Cash in Bank

£99.92M

Increased by £45.22M (+83%)

Net Assets

£694.86M

Decreased by £12.77M (-2%)

Total Liabilities

£105.11M

Increased by £39.17M (+59%)

Turnover

£344.32M

Increased by £131.40M (+62%)

Employees

Increased by 1 (+8%)

Debt Ratio

13%

Increased by 4 (+44%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 31 Dec Year End	2023 31 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (3)

Investor Name	Investor Since	Participating Rounds
Investor 1	May 2018	Series C
Investor 2	May 2018	Series C
Investor 3	May 2018	Series C

Share Capital

Share allotments and capital structure

1 Allotment 1 Shares £431.26m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
7 Jan 2021	ORDINARY	1	£431.26m	£431.26m

Officers

0 active 3 resigned

Show resigned officers

						Status
No officers found

No officers found

Shareholders

Shareholders (1)


Kiniksa Pharmaceuticals International, Plc	100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Kiniksa Pharmaceuticals International, Plc

Unknown

Active

Notified 27 Jun 2024

Nature of Control

Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Kiniksa Pharmaceuticals, Ltd.

Ceased 27 Jun 2024

Ceased

Group Structure

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC united kingdom

KINIKSA PHARMACEUTICALS (UK), LTD. Current Company

Charges

No charges registered

Properties

0 total

No related properties

Documents

Company Filings

Date	Category	Description
28 Nov 2025	Officers	Change to director Mr Mark Anthony Ragosa on 17 Nov 2025
28 Nov 2025	Address	Change Registered Office Address Company With Date Old Address New Address
14 Nov 2025	Confirmation Statement	Confirmation statement made on 14 Nov 2025 with no updates
4 Nov 2025	Address	Change Registered Office Address Company With Date Old Address New Address
4 Nov 2025	Address	Change Registered Office Address Company With Date Old Address New Address

28 Nov 2025 Officers

Change to director Mr Mark Anthony Ragosa on 17 Nov 2025

28 Nov 2025 Address